دورية أكاديمية
Differentiation of Tumorigenic C6 Glioma Cells Induced by Enhanced IL-6 Signaling
| العنوان: | Differentiation of Tumorigenic C6 Glioma Cells Induced by Enhanced IL-6 Signaling |
|---|---|
| المؤلفون: | Inn-Ray Chu, Rong-Long Pan, Chung-Shi Yang |
| المصدر: | Medicina, Vol 56, Iss 625, p 625 (2020) |
| بيانات النشر: | MDPI AG |
| سنة النشر: | 2020 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | cancer stem cell, differentiation therapy, interleukin-6, glial fibrillary acidic protein, soluble interleukin-6 receptor, tumor necrosis factor-α, Medicine (General), R5-920 |
| الوصف: | Background and objectives : Cancer stem cells (CSCs) are obstacles to cancer therapy due to their therapeutic resistance, ability to initiate neoplasia, and roles in tumor relapse and metastasis. Efforts have been made to cure CSCs, such as the use of differentiation therapy, which induces cancer stem-like cells to undergo differentiation and decrease their tumorigenicity. Interleukin 6 (IL-6) upregulates the expression of glial fibrillary acidic protein (GFAP) in C6 glioma cells, indicating that it is able to induce the differentiation of these cells. The C6 glioma cell line forms a high percentage of cancer stem-like cells, leading us to speculate whether IL-6 signaling could modulate the differentiation of tumorigenic C6 glioma cells. However, we observed that IL-6 alone could not efficiently induce the differentiation of these cells. Therefore, different IL-6 signaling elicitors, including IL-6 alone, a combination of IL-6 and soluble IL-6 receptor (IL-6/sIL-6R), and tumor necrosis factor-α (TNF-α) plus IL-6/sIL-6R (TNF-α/IL-6/sIL-6R), were evaluated for their potential use in differentiation therapy. Materials and Methods : The potential of IL-6 signaling elicitors in differentiation therapy were examined by assessing changes in biomarker levels, the rate of cell proliferation, and tumorigenicity, respectively. Results : Enhanced IL-6 signaling could effectively induce C6 glioma cell differentiation, as determined by observed variations in the expression of differentiation, cell cycle, and stem cell biomarkers. Additionally, the total cell population and the tumorigenicity of glioma cells were all considerably reduced after TNF-α/IL-6/sIL-6R treatment. Conclusions : Our findings provide evidence that enhanced IL-6 signaling can efficiently promote tumorigenic C6 glioma cells to undergo differentiation. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1010-660X |
| العلاقة: | https://www.mdpi.com/1010-660X/56/11/625Test; https://doaj.org/toc/1010-660XTest; https://doaj.org/article/7334a687f8594cd495590162411b218aTest |
| DOI: | 10.3390/medicina56110625 |
| الإتاحة: | https://doi.org/10.3390/medicina56110625Test https://doaj.org/article/7334a687f8594cd495590162411b218aTest |
| رقم الانضمام: | edsbas.527BE6FD |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 1010660X |
|---|---|
| DOI: | 10.3390/medicina56110625 |